REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT05744921 updates: 1. completion date: 2029-02-26 → 2028-10-10 2. primary completion date: 2029-02-26 → 2028-10-10
Clinical trial NCT05744921 updates: 1. completion date: 2029-02-26 → 2028-10-10 2. primary completion date: 2029-02-26 → 2028-10-10
📉 **NEGATIVE** • Medium confidence analysis (63%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical